Effect of Remote Ischemic Preconditioning on Children Undergoing Cardiac Surgery
1 other identifier
interventional
60
1 country
2
Brief Summary
This study is conducted in order to evaluate the effect of remote ischemic preconditioning on children undergoing cardiac surgery, especially focusing on possible differences according to preoperative cyanosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2009
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 20, 2009
CompletedStudy Start
First participant enrolled
October 1, 2009
CompletedFirst Posted
Study publicly available on registry
March 9, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedMay 1, 2012
March 1, 2011
1.7 years
September 20, 2009
April 30, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
troponin level
troponin level will be checked 1, 6, 12 and 24 hours after operation. Ater making a graph (troponin-time), area under the curve will bw calculated.
within the 1 day after operation
Study Arms (1)
remote ischemic preconditioning
EXPERIMENTALInterventions
RIPC will be performed by four 5-min cycles of lower limb ischemia and 5 in reperfusion using blood-pressure cuff inflated to a pressure 15 mmHg greater than the systolic arterial pressure measured via arterial line.
Eligibility Criteria
You may qualify if:
- open heart surgery under cardiopulmonary bypass: ventricular septal defect, tetralogy of Fallot
You may not qualify if:
- chromosomal defect
- airway and parenchymal lung disease blood disorder
- isolated atrail septal defect
- immunodeficiency
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Seoul National University Hospital
Seoul, Seoul, 110-744, South Korea
Seoul national university hospital
Seoul, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant professor
Study Record Dates
First Submitted
September 20, 2009
First Posted
March 9, 2011
Study Start
October 1, 2009
Primary Completion
July 1, 2011
Study Completion
December 1, 2011
Last Updated
May 1, 2012
Record last verified: 2011-03